Do you find our website to be helpful?
Yes   No

Research & Press


Research Utilizing Ketamine In Mood Disorders


​​​​​A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.

​​​​Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants​.

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial.

​​​​​A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression.

Efficacy of IV Ketamine for Treatment of Chronic Posttraumatic Stress Disorder.

Glutamate NMDA receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

​​​​​Ketamine as a Novel Antidepressant: From Synapse to Behavior.

Maintenance Ketamine Treatment Produces Long-term Recovery from Depression.

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression.

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-Of-Concept.

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression.

Serial infusions of low-dose ketamine for major depression.

​​​​Synaptic dysfunction in depression: potential therapeutic targets.

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial




Research Utilizing Ketamine In ​Chronic Pain


Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review.

​​​​Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.

Differential Efficacy of Ketamine in the Acute versus Chronic Stages of Complex Regional Pain Syndrome in Mice.

Is magnesium sulfate effective for pain in chronic postherpetic neuralgia patients comparing with ketamine infusion therapy?

​​​​Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study.

Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.

​​​​​The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia.

Rational pain management in complex regional pain syndrome 1 (CRPS 1)--a network meta-analysis.

​​​​​Ketamine may help treat migraine pain unresponsive to other therapies.

Our Locations

Choose your preferred location